Adam Whitehead
Internal Medicine · Wappingers Falls, NYNPI 1780687236
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,641 of the $3,008 with a category attached, or 87.8%. 27 manufacturers reported payments, led by Equashield LLC at 25.5% of the total. Reporting peaked in 2019 at $1,875 and has fallen 93.3% since, to $126 in 2025.
Across 129 payments — averaging $23.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Equashield LLC$767
- Amarin Pharma, Inc.$324
- GSK$221
- Grifols USA, LLC$186
- Johnson & Johnson$175
- Kowa Pharmaceuticals America, Inc.$157
- plus $1K from 21 others
What the payments were for
- Consulting fees$34511%
- Food & beverage$2,64188%
- Education$221%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Equashield LLC | 5 | $767 |
| Amarin Pharma, Inc. | 15 | $324 |
| GSK | 11 | $221 |
| Grifols USA, LLC | 4 | $186 |
| Johnson & Johnson(2 entities) | 11 | $175 |
| Kowa Pharmaceuticals America, Inc. | 11 | $157 |
| Lilly USA, LLC | 7 | $134 |
| Amgen | 7 | $130 |
| Pfizer | 10 | $118 |
| AstraZeneca | 8 | $106 |
| Regeneron Healthcare Solutions, Inc. | 5 | $105 |
| Novo Nordisk | 5 | $98 |
| AbbVie(2 entities) | 5 | $92 |
| Sanofi-aventis U.S. LLC | 3 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $46 |
| Teva Pharmaceuticals USA, Inc. | 3 | $46 |
| Mylan Specialty L.p. | 2 | $39 |
| IBSA Pharma Inc. | 2 | $29 |
| Arbor Pharmaceuticals, Inc. | 2 | $26 |
| Merck | 2 | $26 |
| Boehringer Ingelheim | 1 | $25 |
| E.r. Squibb & Sons, L.L.C. | 1 | $23 |
| Fresenius USA Marketing, Inc. | 1 | $19 |
| Pharming Healthcare, Inc. | 1 | $17 |
| Therapeuticsmd, Inc. | 1 | $16 |
| Abbott | 1 | $15 |
| Electromed, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Equashield$126
- Prolastin-C$125
- Vascepa$125
How this compares
$3,008 in reported general payments places this provider in the 85th percentile of 9,771 internal medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Allopurinol | 13 | $172 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Wappingers Falls
- David DoveEast Hampton$12.3M
- Bruce BergerBrooklyn$3.4M
- Nicholas RobinsonBuffalo$2.9M
- Stephen SaletanNew York$2.6M
- Ziad AliNew York$2M
- Scott BeegleAlbany$1.9M
- Anthony MartinezBuffalo$1.6M
- Javier MoralesGreenvale$1.3M
- Ricky HsuNew York$1M
- James UnderbergNew York$953K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.